Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 90 Neoplasms, Plasma Cell 28 Central Nervous System Neoplasms 11 Recurrence 10 Glioblastoma 10 Neoplasms 9 Carcinoma, Hepatocellular 9 Brain Neoplasms 9 Gliosarcoma 8 Melanoma 6 Lung Neoplasms 6 Leukemia 6 Glioma 6 Carcinoma, Non-Small-Cell Lung 6 Waldenstrom Macroglobulinemia 5 Prostatic Neoplasms 5 Lymphoma, Mantle-Cell 5 Myeloproliferative Disorders 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Immunoglobulin Light-chain Amyloidosis 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Astrocytoma 4 Uveal Melanoma 3 Oligodendroglioma 3 Neuroblastoma 3 Myelodysplastic-Myeloproliferative Diseases 3 Myelodysplastic Syndromes 3 Medulloblastoma 3

Interventions

Megestrol Acetate 9 Mirtazapine 5 Olanzapine 4 anamorelin 2 nabiximols 1 nabilone 1 Watchful Waiting 1 Thalidomide 1 Surveys and Questionnaires 1 Sugars 1 Radiotherapy 1 Quality of Life 1 Palonosetron 1 Observation 1 Nicotine 1 Modafinil 1 Minocycline 1 Melatonin 1 Megestrol 1 Magnetic Resonance Spectroscopy 1 Infliximab 1 Flurandrenolone 1 Etanercept 1 Eicosapentaenoic Acid 1 Dronabinol 1 Docetaxel 1 Dexamethasone 1 Creatine 1 Calcium Dobesilate 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Anorexia × Thalidomide × Clear all

NCT00379353 2013-02-04

The Effects of Thalidomide on Symptom Clusters

M.D. Anderson Cancer Center

Phase 2 Completed

32 enrolled 14 charts

Anorexia, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡